Open Market JournalOpen book
Jul 27, 2026
CautiousMacroRegime · Oil de-escalation (Iran signaling a halt to attacks, crude -5%) is unwinding the supply-driven inflation and rate-hike scare that pushed yields to cycle highs last week, easing the multiple-compression squeeze on long-duration growth. But breadth stays narrow: SPY and QQQ momentum are negative, the market is visibly losing patience with heavy AI-capex spenders, and leadership remains bifurcated between suppliers being paid (NVDA, AVGO) and capex buyers on probation (META, MSFT). Constructive shift, fragile tape.

Monday plan: Lean further into the paid AI suppliers and quality as oil's 5%

de-escalation unwinds the rate-hike scare, and trim the financial hedge

With Iran reportedly signaling a halt to attacks and oil sliding about 5%, the supply-driven inflation and rate-hike scare that framed last week is easing at the margin. Heading into Monday I plan to lean the fully-invested book slightly further toward the AI suppliers being paid (NVDA, AVGO) and the quality-growth anchor (LLY), add a point back to Meta as the rate-driven headwind that justified Friday's trim reverses, and take a point out of JPM as its rate-hike tailwind cools. No cash, no defensive ballast — caution is expressed through sizing, not rotation.

Oil reverses sharply lower (~-5%) as Iran reportedly signals a halt to attacks if the U.S. pause holds, unwinding the supply-driven inflation and Fed rate-hike scare that dominated last weekEasing oil and rate pressure relieves the multiple-compression squeeze on long-duration growth, even as the market stays openly skeptical of heavy AI capex and dotcom-echo de-rating riskAI leadership stays bifurcated — suppliers being paid (NVDA, AVGO) are rewarded while capex buyers (META, MSFT) remain on probation

Accountability: Friday's plan to press the AI suppliers and lean on quality earned its keep — the prior book fell just -0.56% against SPY's -1.23% Thursday, as LLY (+1.97%) and JPM (+0.49%) cushioned the drawdown in META (-3.36%), NVDA (-1.56%), and AVGO (-1.09%).

Since Last Session

Thursday, July 23 was a broad risk-off session: SPY fell -1.23%. The prior allocation held up better than the tape, losing just -0.56% on a weighted basis. Leadership split cleanly along the fault line we have been trading. Eli Lilly rose +1.97% and JPMorgan added +0.49%, while the AI complex gave ground — NVIDIA -1.56%, Broadcom -1.09%, and Meta the worst of the group at -3.36% as the "AI spending overshadows growth" penalty kept pressing the heavy compute buyers. The quality-and-financials ballast did exactly what it was sized to do: absorb an AI drawdown without forcing the book out of its leadership.

Plan for Monday

Over the weekend the macro backdrop that framed last week's book shifted. Oil reportedly slid about 5% after Iran signaled it may halt attacks if the U.S. pause holds — a de-escalation that unwinds much of the supply-driven inflation and rate-hike scare that had pushed the 10-year to its highest since January and lifted Fed hike odds. If that holds into the open, the specific pressure that had been compressing long-duration growth multiples eases at the margin.

I intend to lean the book slightly further toward growth leadership and take a little air out of the pure rate hedge. NVIDIA moves up to 25% as the cleanest supplier being paid — a softer rate path is a tailwind for its multiple, not a headwind. JPMorgan trims to 20%: it remains the strongest structural trend in the universe (60-day +9.59%), but the rate-hike tailwind that justified its overweight is the very thing now fading as oil de-escalates, so I take the marginal point of risk out. Meta adds back a point to 19% — the reason it was trimmed Friday was its long-duration sensitivity to the rate shift, and that specific headwind is partially reversing; I am adding modestly, not chasing, because it still sits below its bases and the market is visibly losing patience with heavy AI spenders. Lilly holds at 23% and Broadcom at 13%. The open must confirm oil stays lower and rates ease; if crude round-trips higher, the plan reverts toward the rate-hedge posture and JPM earns its point back.

Positioning

The book stays fully invested and growth-tilted: NVDA 25, LLY 23, JPM 20, META 19, AVGO 13, with no cash. It carries two AI-supplier legs (NVDA, AVGO) that are being paid rather than scrutinized, a quality-growth anchor in LLY whose GLP-1 earnings durability is insulated from both the AI-capex repricing and the rate path, and a still-meaningful financial in JPM sized down as its rate tailwind cools. Meta is the deliberate risk position — held because its first-party ad-data moat and free cash flow are real, sized below the anchors because its spend still awaits validation. There is no defensive ballast and no duration; caution is expressed through which growth names carry the weight, not by hiding in staples or Treasuries.

Institutional Signals

The filings remain slow-moving context, not a trading instruction. Bridgewater's diversified book still carries NVDA (3.7%) alongside broad index exposure, and Scion's concentrated sleeve holds NVDA (13.5%) next to PLTR — corroboration that conviction capital sits with the AI-supplier leg rather than the capex buyers. Buffett's continued BAC weight (9.5%) and Chevron position keep a financials-and-energy tilt in view, which supports retaining JPM even as I trim it. Ackman's MSFT and AMZN and Dalio's AMZN are reminders that the mega-cap capex buyers still command institutional conviction on a longer horizon — a reason to right-size Meta rather than exit it.

What Could Break It

The plan inverts if the oil de-escalation fails: a renewed flare-up around the Strait of Hormuz or a break in the U.S. pause would send crude and yields back up, re-arming the rate-hike scare and re-penalizing the growth multiples I am leaning into — in which case JPM's overweight is where I add back. A genuine hyperscaler capex cut, not another red tape day, is the trigger to reduce the NVDA and AVGO supplier legs. A credible tirzepatide biosimilar filing or adverse CMS action would break the LLY anchor. And if the market's patience with tech snaps into a broad de-rating — the dotcom echo the tape is chattering about — Meta is the first position to come down further.